Fundamentals for Alliance Pharma ( aph )
Current Price: 0.42
Market Cap: 226.97m
Price / Net Assets: 0.79
Internal Rate of Return: 21.22%
PE10 Ratio: 17.57
Dividend Yield: 4.24%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | Average |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £167.42m | £163.21m | £129.8m | £135.64m | £118.21m | £97.49m | £48.34m | £43.54m | £113m |
| Revenue Growth | 2.58% | 25.74% | -4.31% | 14.74% | 21.25% | 101.68% | 11.02% | - | 25% |
| Profit / Loss | £0.94m | £7.32m | £8.03m | £25.01m | £18.36m | £18.09m | £12.69m | £8.38m | £12m |
| Profit Increase/Decrease | -87.16% | -8.84% | -67.89% | 36.22% | 1.49% | 42.55% | 51.43% | - | -5% |
| Profit / Sales Ratio | 0.56% | 4.49% | 6.19% | 18.44% | 15.53% | 18.56% | 26.25% | 19.25% | 15% |
| Earnings per Share | £0.00 | £0.01 | £0.02 | £0.05 | £0.04 | £0.04 | £0.05 | £0.03 | £0.03 |
| Total Debt | £249.75m | £221.00m | £227.89m | £133.46m | £151.41m | £141.74m | £120.56m | £37.09m | £160.36m |
| Net Assets | £287.66m | £282.49m | £280.96m | £274.18m | £252.20m | £179.26m | £162.44m | £70.78m | £223.75m |
| Debt / Asset Ratio | 46.47% | 43.89% | 44.79% | 32.74% | 37.51% | 44.16% | 42.60% | 34.38% | 34.38% |
| Dividend per Share | 1.78 | 1.69 | 1.61 | 0.54 | 1.46 | 1.21 | 1.10 | 1.00 | 1.30 |
| Dividend per Share Growth | 5.03% | 5.03% | 200.37% | -63.39% | 0% | 10% | 10% | 10.13% | 22.15% |
| Dividend Cover | 2.41x | 3.78x | 3.17x | 9.5x | 3.1x | 3.18x | 3.2x | 3.36x | 3.96x |